These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30910857)

  • 1. Direct healthcare costs of sedentary behaviour in the UK.
    Heron L; O'Neill C; McAneney H; Kee F; Tully MA
    J Epidemiol Community Health; 2019 Jul; 73(7):625-629. PubMed ID: 30910857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the potential health and economic benefits of reducing population sitting time in Australia.
    Nguyen P; Ananthapavan J; Tan EJ; Crosland P; Bowe SJ; Gao L; Dunstan DW; Moodie M
    Int J Behav Nutr Phys Act; 2022 Mar; 19(1):28. PubMed ID: 35305678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costing the economic burden of prolonged sedentary behaviours in France.
    Noël Racine A; Margaritis I; Duclos M; Carré F; Vuillemin A; Gautier C
    Eur J Public Health; 2022 Aug; 32(Suppl 1):i3-i7. PubMed ID: 36031819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of excessive sedentary behaviour in Canada.
    Chaput JP; Janssen I; Lang JJ; Sampasa-Kanyinga H
    Can J Public Health; 2023 Apr; 114(2):165-174. PubMed ID: 36696033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
    Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
    PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care costs of physical inactivity in Canadian adults.
    Janssen I
    Appl Physiol Nutr Metab; 2012 Aug; 37(4):803-6. PubMed ID: 22667697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of smoking-related ill health in the UK.
    Allender S; Balakrishnan R; Scarborough P; Webster P; Rayner M
    Tob Control; 2009 Aug; 18(4):262-7. PubMed ID: 19509003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of obesity in Canada.
    Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
    CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare Expenditure and Productivity Cost Savings from Reductions in Cardiovascular Disease and Type 2 Diabetes Associated with Increased Intake of Cereal Fibre among Australian Adults: A Cost of Illness Analysis.
    Fayet-Moore F; George A; Cassettari T; Yulin L; Tuck K; Pezzullo L
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29301298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of low physical activity and high sedentary behaviour in Finland.
    Kolu P; Kari JT; Raitanen J; Sievänen H; Tokola K; Havas E; Pehkonen J; Tammelin TH; Pahkala K; Hutri-Kähönen N; Raitakari OT; Vasankari T
    J Epidemiol Community Health; 2022 Jul; 76(7):677-684. PubMed ID: 35473717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic impact of sight loss and blindness in the UK adult population.
    Pezzullo L; Streatfeild J; Simkiss P; Shickle D
    BMC Health Serv Res; 2018 Jan; 18(1):63. PubMed ID: 29382329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis.
    Santos AC; Willumsen J; Meheus F; Ilbawi A; Bull FC
    Lancet Glob Health; 2023 Jan; 11(1):e32-e39. PubMed ID: 36480931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current cost of heart failure to the National Health Service in the UK.
    Stewart S; Jenkins A; Buchan S; McGuire A; Capewell S; McMurray JJ
    Eur J Heart Fail; 2002 Jun; 4(3):361-71. PubMed ID: 12034163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overweight and obesity on the island of Ireland: an estimation of costs.
    Dee A; Callinan A; Doherty E; O'Neill C; McVeigh T; Sweeney MR; Staines A; Kearns K; Fitzgerald S; Sharp L; Kee F; Hughes J; Balanda K; Perry IJ
    BMJ Open; 2015 Mar; 5(3):e006189. PubMed ID: 25776042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation and Prediction of Avoidable Health Care Costs of Cardiovascular Diseases and Type 2 Diabetes Through Adequate Dairy Food Consumption: A Systematic Review and Micro Simulation Modeling Study.
    Javanbakht M; Jamshidi AR; Baradaran HR; Mohammadi Z; Mashayekhi A; Shokraneh F; Rezai Hamami M; Yazdani Bakhsh R; Shabaninejad H; Delavari S; Tehrani A
    Arch Iran Med; 2018 May; 21(5):213-222. PubMed ID: 29738265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of cardiovascular diseases in the United Kingdom.
    Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M
    Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of physical inactivity in Canada.
    Katzmarzyk PT; Gledhill N; Shephard RJ
    CMAJ; 2000 Nov; 163(11):1435-40. PubMed ID: 11192648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden of type 2 diabetes on the public healthcare system in Kenya: a cost of illness study.
    Karugu CH; Agyemang C; Ilboudo PG; Boachie MK; Mburu L; Wanjohi M; Sanya RE; Moolla A; Ojiambo V; Kruger P; Vandevijvere S; Asiki G
    BMC Health Serv Res; 2024 Oct; 24(1):1228. PubMed ID: 39402597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.